5.27
전일 마감가:
$5.52
열려 있는:
$5.54
하루 거래량:
545.55K
Relative Volume:
0.19
시가총액:
$362.30M
수익:
-
순이익/손실:
$-87.23M
주가수익비율:
-1.7744
EPS:
-2.97
순현금흐름:
$-82.77M
1주 성능:
-9.91%
1개월 성능:
-1.50%
6개월 성능:
+273.76%
1년 성능:
+22.56%
Pepgen Inc Stock (PEPG) Company Profile
명칭
Pepgen Inc
전화
703-456-8000
주소
1 MARINA PARK DRIVE, SUITE 900, BOSTON
PEPG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PEPG
Pepgen Inc
|
5.27 | 379.49M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-09 | 개시 | Guggenheim | Buy |
| 2024-12-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-07-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-21 | 개시 | H.C. Wainwright | Buy |
Pepgen Inc 주식(PEPG)의 최신 뉴스
What analysts say about PepGen Inc stockMarket Sentiment Shifts & Watch and Learn From Live Trades - earlytimes.in
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PepGen Inc. (PEPG) And Encourages Stockholders to Reach Out - ACCESS Newswire
PepGen appoints Joseph Vittiglio as chief business, legal officer - MSN
Movement Recap: How buybacks impact PepGen Inc stock valueQuarterly Growth Report & Daily Profit Maximizing Trade Tips - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - ACCESS Newswire
How Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44% - Zacks Investment Research
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer - BioSpace
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer - BioSpace
Quant Funds Rotate Into Lead Reclaim and Rubber Products Limited StockSwing Trading Ideas & Superior Wealth Growth - earlytimes.in
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
PepGen (NASDAQ:PEPG) Targets Next-Gen Treatment Pathways In Biotech - Kalkine Media
PepGen appoints Joseph Vittiglio as chief business and legal officer - Investing.com
PepGen appoints Joseph Vittiglio, Esq., as chief business and legal officer - marketscreener.com
PepGen Inc. Appoints New Chief Business Officer - TipRanks
PepGen appoints Joseph Vittiglio as chief business and legal officer By Investing.com - Investing.com Canada
PepGen Inc Appoints New Chief Business and Legal Officer - TradingView — Track All Markets
Pepgen Inc. Appoints Joseph Vittiglio as Chief Business and Legal Officer, Effective December 8, 2025 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PepGen (PEPG) Stock Analysis Report | Financials & Insights - Benzinga
PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Class Action Lawsuit Filed Against PepGen Inc. (PEPG)Recover L - The National Law Review
Lost Money on PepGen Inc. (PEPG)? Join Class Action Before August 8, 2025Contact Levi & Korsinsky - The National Law Review
PepGen (PEPG) Price Target Increased by 17.65% to 10.20 - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PepGen Inc. (PEPG) And Encourages Shareholders to Reach Out - ACCESS Newswire
PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Aktiellt
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - ADVFN
What date does PepGen's (PEPG) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
32,799,724 Common Stock of PepGen Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2025. - MarketScreener
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Compugen (NASDAQ:CGEN) versus PepGen (NASDAQ:PEPG) Critical Review - Defense World
Can PepGen Inc. stock beat analyst upgradesMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Why retail investors pile into PepGen Inc. stockDividend Hike & Safe Capital Growth Stock Tips - newser.com
Will PepGen Inc. price bounce be sustainable2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
What risks investors should watch in PepGen Inc. stockMarket Performance Report & Capital Protection Trading Alerts - newser.com
PepGen Inc. (PEPG) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
PepGen Investor Drops Suit Over Muscular Dystrophy Drug Study - Bloomberg Law News
Can PepGen Inc. stock attract ESG capital inflows2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Will PepGen Inc. see short term momentumShort Setup & Safe Entry Momentum Stock Tips - newser.com
Smart tools for monitoring PepGen Inc.’s price actionPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
Advanced analytics toolkit walkthrough for PepGen Inc.2025 Volatility Report & Stepwise Swing Trade Plans - newser.com
Pepgen Inc (PEPG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):